ACE-Hemmer bei kardialen Hochrisikopatienten Primäranalyse der HOPE-Studie View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-03

AUTHORS

B. Schieffer, H. Drexler, W. Lehmacher

ABSTRACT

(sn) Bei Patienten mit linksventrikulärer Dysfunktion sind ACE-Hemmer, unabhängig davon ob eine klinisch relevante Herzinsuffizienz besteht, derzeit das Therapeutikum der Wahl. Epidemiologische und experimentelle Untersuchungen lassen vermuten, dass die Aktivierung des Renin-Angiotensin-Aldosteron-Systems das Risiko kardiovaskulärer Ereignisse nicht nur bei herzinsuffizienten Patienten erhöht. Durch ACE-Hemmer wird diese Aktivierung verhindert, daher war die Evaluierung der präventiven Gabe von ACE-Hemmern bei kardialen Hochrisikopatienten ohne linksventrikuläre Insuffizienz ein Ziel der nachfolgend vorgestellten HOPE-Studie. More... »

PAGES

431-434

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2

DOI

http://dx.doi.org/10.1007/s00108-002-0548-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036671496

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11963727


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiotensin-Converting Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ramipril", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Dysfunction, Left", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medizinische Hochschule Hannover, DE", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Medizinische Hochschule Hannover, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schieffer", 
        "givenName": "B.", 
        "id": "sg:person.01075113266.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075113266.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medizinische Hochschule Hannover, DE", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Medizinische Hochschule Hannover, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Drexler", 
        "givenName": "H.", 
        "id": "sg:person.010063330502.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010063330502.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut f\u00fcr Medizinische Statistik, Informatik und Epidemiologie, K\u00f6ln, DE", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institut f\u00fcr Medizinische Statistik, Informatik und Epidemiologie, K\u00f6ln, DE"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehmacher", 
        "givenName": "W.", 
        "type": "Person"
      }
    ], 
    "datePublished": "2002-03", 
    "datePublishedReg": "2002-03-01", 
    "description": "Abstract(sn) Bei Patienten mit linksventrikul\u00e4rer Dysfunktion sind ACE-Hemmer, unabh\u00e4ngig davon ob eine klinisch relevante Herzinsuffizienz besteht, derzeit das Therapeutikum der Wahl. Epidemiologische und experimentelle Untersuchungen lassen vermuten, dass die Aktivierung des Renin-Angiotensin-Aldosteron-Systems das Risiko kardiovaskul\u00e4rer Ereignisse nicht nur bei herzinsuffizienten Patienten erh\u00f6ht. Durch ACE-Hemmer wird diese Aktivierung verhindert, daher war die Evaluierung der pr\u00e4ventiven Gabe von ACE-Hemmern bei kardialen Hochrisikopatienten ohne linksventrikul\u00e4re Insuffizienz ein Ziel der nachfolgend vorgestellten HOPE-Studie.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00108-002-0548-2", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1399751", 
        "issn": [
          "0020-9554", 
          "1432-1289"
        ], 
        "name": "Der Internist", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "43"
      }
    ], 
    "keywords": [
      "Renin-Angiotensin", 
      "bei", 
      "DAS", 
      "DERs", 
      "Ziel", 
      "Wahl", 
      "war"
    ], 
    "name": "ACE-Hemmer bei kardialen Hochrisikopatienten Prim\u00e4ranalyse der HOPE-Studie", 
    "pagination": "431-434", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036671496"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00108-002-0548-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11963727"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00108-002-0548-2", 
      "https://app.dimensions.ai/details/publication/pub.1036671496"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_347.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00108-002-0548-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00108-002-0548-2'


 

This table displays all metadata directly associated to this object as RDF triples.

128 TRIPLES      20 PREDICATES      44 URIs      36 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00108-002-0548-2 schema:about N2760daa36ead4509a6d5c47669e71c95
2 N2adaa06ebd6f4704bf1a10a0b606f9c3
3 N2cc04560bee14c87add9b60392fcd448
4 N4b769caf81374facae5549bcf0041dc1
5 N6252a64ddec64457bbafe19cb30dd999
6 N7cd2e382e29f406dac45b1890a94fb26
7 N8399cc295eaf432cab1a24f1cae65395
8 N87bdf1a34d8a4990ae67536d633626c0
9 N949c61d3b0684ae4960f7458eefc7247
10 Na41ea5d7a01044709626c95c147580da
11 Nb4d4a2956dd44218908ca4ec8f690b49
12 anzsrc-for:11
13 anzsrc-for:1116
14 schema:author N6a924078995c4102a3f9ed4d3456f989
15 schema:datePublished 2002-03
16 schema:datePublishedReg 2002-03-01
17 schema:description Abstract(sn) Bei Patienten mit linksventrikulärer Dysfunktion sind ACE-Hemmer, unabhängig davon ob eine klinisch relevante Herzinsuffizienz besteht, derzeit das Therapeutikum der Wahl. Epidemiologische und experimentelle Untersuchungen lassen vermuten, dass die Aktivierung des Renin-Angiotensin-Aldosteron-Systems das Risiko kardiovaskulärer Ereignisse nicht nur bei herzinsuffizienten Patienten erhöht. Durch ACE-Hemmer wird diese Aktivierung verhindert, daher war die Evaluierung der präventiven Gabe von ACE-Hemmern bei kardialen Hochrisikopatienten ohne linksventrikuläre Insuffizienz ein Ziel der nachfolgend vorgestellten HOPE-Studie.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf N1e7d638c043a4aad8e6caafe4cfd5be9
21 N728a6a9f12934535b4c43e6888d677b3
22 sg:journal.1399751
23 schema:keywords DAS
24 DERs
25 Renin-Angiotensin
26 Wahl
27 Ziel
28 bei
29 war
30 schema:name ACE-Hemmer bei kardialen Hochrisikopatienten Primäranalyse der HOPE-Studie
31 schema:pagination 431-434
32 schema:productId N1715765923454c8292da6821d40956ee
33 Nbe29ad6654454593ab95248e1d28c11f
34 Ndb5aac3e1a8949da9ea138d8046e2605
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036671496
36 https://doi.org/10.1007/s00108-002-0548-2
37 schema:sdDatePublished 2022-12-01T06:23
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N2c6eed8860c14e8f956bb45a5ec189e5
40 schema:url https://doi.org/10.1007/s00108-002-0548-2
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N1715765923454c8292da6821d40956ee schema:name pubmed_id
45 schema:value 11963727
46 rdf:type schema:PropertyValue
47 N1e7d638c043a4aad8e6caafe4cfd5be9 schema:volumeNumber 43
48 rdf:type schema:PublicationVolume
49 N2760daa36ead4509a6d5c47669e71c95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name Angiotensin-Converting Enzyme Inhibitors
51 rdf:type schema:DefinedTerm
52 N2adaa06ebd6f4704bf1a10a0b606f9c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name Humans
54 rdf:type schema:DefinedTerm
55 N2c6eed8860c14e8f956bb45a5ec189e5 schema:name Springer Nature - SN SciGraph project
56 rdf:type schema:Organization
57 N2cc04560bee14c87add9b60392fcd448 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Dose-Response Relationship, Drug
59 rdf:type schema:DefinedTerm
60 N32078a159d6442869d90c6924b34e6d4 rdf:first Nfcba779903624494af206f9249cbdb83
61 rdf:rest rdf:nil
62 N4b769caf81374facae5549bcf0041dc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Male
64 rdf:type schema:DefinedTerm
65 N6252a64ddec64457bbafe19cb30dd999 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Ventricular Dysfunction, Left
67 rdf:type schema:DefinedTerm
68 N6a924078995c4102a3f9ed4d3456f989 rdf:first sg:person.01075113266.30
69 rdf:rest N8eed2cc25d7e48b695519f881d772388
70 N728a6a9f12934535b4c43e6888d677b3 schema:issueNumber 3
71 rdf:type schema:PublicationIssue
72 N7cd2e382e29f406dac45b1890a94fb26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Female
74 rdf:type schema:DefinedTerm
75 N8399cc295eaf432cab1a24f1cae65395 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Middle Aged
77 rdf:type schema:DefinedTerm
78 N87bdf1a34d8a4990ae67536d633626c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Ramipril
80 rdf:type schema:DefinedTerm
81 N8eed2cc25d7e48b695519f881d772388 rdf:first sg:person.010063330502.67
82 rdf:rest N32078a159d6442869d90c6924b34e6d4
83 N949c61d3b0684ae4960f7458eefc7247 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Double-Blind Method
85 rdf:type schema:DefinedTerm
86 Na41ea5d7a01044709626c95c147580da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Aged
88 rdf:type schema:DefinedTerm
89 Nb4d4a2956dd44218908ca4ec8f690b49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Survival Rate
91 rdf:type schema:DefinedTerm
92 Nbe29ad6654454593ab95248e1d28c11f schema:name dimensions_id
93 schema:value pub.1036671496
94 rdf:type schema:PropertyValue
95 Ndb5aac3e1a8949da9ea138d8046e2605 schema:name doi
96 schema:value 10.1007/s00108-002-0548-2
97 rdf:type schema:PropertyValue
98 Nfcba779903624494af206f9249cbdb83 schema:affiliation grid-institutes:None
99 schema:familyName Lehmacher
100 schema:givenName W.
101 rdf:type schema:Person
102 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
103 schema:name Medical and Health Sciences
104 rdf:type schema:DefinedTerm
105 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical Physiology
107 rdf:type schema:DefinedTerm
108 sg:journal.1399751 schema:issn 0020-9554
109 1432-1289
110 schema:name Der Internist
111 schema:publisher Springer Nature
112 rdf:type schema:Periodical
113 sg:person.010063330502.67 schema:affiliation grid-institutes:grid.10423.34
114 schema:familyName Drexler
115 schema:givenName H.
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010063330502.67
117 rdf:type schema:Person
118 sg:person.01075113266.30 schema:affiliation grid-institutes:grid.10423.34
119 schema:familyName Schieffer
120 schema:givenName B.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075113266.30
122 rdf:type schema:Person
123 grid-institutes:None schema:alternateName Institut für Medizinische Statistik, Informatik und Epidemiologie, Köln, DE
124 schema:name Institut für Medizinische Statistik, Informatik und Epidemiologie, Köln, DE
125 rdf:type schema:Organization
126 grid-institutes:grid.10423.34 schema:alternateName Medizinische Hochschule Hannover, DE
127 schema:name Medizinische Hochschule Hannover, DE
128 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...